Association of intravenous ketamine with change in depressive symptoms in a large integrated health care system.
Psychiatry Research 2025 Li Kevin J, Slama Natalie E, Chen Ingrid et al.
Racemic ketamine intravenous treatments (KIT) are widely used in community clinics for treatment resistant depression (TRD), but we lack studies on symptom improvement during standardized delivery to clinically complex patients with TRD. We aimed to assess depression symptom change for patients receiving standardized KIT for TRD in a large integrated health care delivery system relative to...